Avita Medical (RCEL) Trading Snapshot
- Last trading session: Flat, unchanged at 0 % over the 24‑hour period ending 08:42 PM Central Europe on Thursday 22 Feb 2027.
- Current price: USD 15.27 per share on major exchanges.
- Shares outstanding: 30.9 million.
- Market capitalization: USD 403.3 million.
- Volume (last 24 hrs): USD 12.9 million.
- Month‑to‑date performance: Up 33.07 % since the end of the previous month.
- 200‑day simple moving average: USD 7.92.
- 52‑week high: USD 15.64 (21 Oct 2026).
- 52‑week low: USD 3.22 (7 Jan 2026).
Upcoming Financial Disclosure
Avita Medical Inc. has announced that it will release its third‑quarter 2026 financial results after the close of U.S. markets on 5 Nov 2026. A conference call and webcast will be held the following day. Management will discuss the results and recent business highlights, particularly the performance of key wound‑care platforms. The company continues to focus on its therapeutic acute wound‑care portfolio, which includes FDA‑approved and internationally licensed products.
Investors are encouraged to review the forthcoming earnings release and participate in the scheduled webcast for detailed financial and operational information.
Related Stock Activity (Last 24 hrs)
| Ticker | Recent Change | Current Price (USD) | Market Cap (USD m) | Notes |
|---|---|---|---|---|
| KRSP | -0.19 % | 10.41 | 482.1 | Rice Acquisition |
| SGHT | +0.93 % | 8.93 | 474.9 | Sight Sciences |
| OPFI | +0.89 % | 5.72 | 479.7 | Oppfi; P/E 2.64 |
| RYAM | -0.14 % | 6.86 | 473.5 | Rayonier Advanced Materials |
| CERS | +3.46 % | 2.29 | 477.6 | Cerus |
Company Overview
Avita Medical, Inc. is a biotechnology company that develops and commercializes therapies for burns, chronic wounds, and aesthetic indications worldwide.
